DarioHealth Corp. (NASDAQ:DRIO – Get Free Report) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,800,000 shares, an increase of 11.1% from the August 15th total of 1,620,000 shares. Based on an average trading volume of 93,900 shares, the days-to-cover ratio is presently 19.2 days.
Hedge Funds Weigh In On DarioHealth
An institutional investor recently bought a new position in DarioHealth stock. Clarity Capital Partners LLC bought a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 170,426 shares of the company’s stock, valued at approximately $293,000. Clarity Capital Partners LLC owned approximately 0.63% of DarioHealth at the end of the most recent reporting period. Hedge funds and other institutional investors own 33.39% of the company’s stock.
DarioHealth Stock Performance
Shares of DRIO stock traded up $0.10 during trading hours on Wednesday, reaching $0.97. The stock had a trading volume of 21,152 shares, compared to its average volume of 118,270. DarioHealth has a twelve month low of $0.68 and a twelve month high of $3.49. The firm has a market capitalization of $29.02 million, a PE ratio of -0.58 and a beta of 1.46. The firm has a 50-day simple moving average of $1.00 and a 200-day simple moving average of $1.28. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96.
DarioHealth Company Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Read More
- Five stocks we like better than DarioHealth
- Buy P&G Now, Before It Sets A New All-Time High
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
- What to Know About Investing in Penny Stocks
- Stocks to Take Advantage of Rising Gold Prices
- When to Sell a Stock for Profit or Loss
- Smartsheet Is a Smart Buy for Traders and Investors: Here’s Why
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.